We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 14, 2021

Molecular Subtypes Associated With Different Responses to Apalutamide in Nonmetastatic Castration-Resistant Prostate Cancer

JAMA Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Oncology
Association of Molecular Subtypes With Differential Outcome to Apalutamide Treatment in Nonmetastatic Castration-Resistant Prostate Cancer
JAMA Oncol 2021 Jun 03;[EPub Ahead of Print], FY Feng, S Thomas, F Saad, M Gormley, MK Yu, DS Ricci, B Rooney, S Brookman-May, S McCarthy, D Olmos, S Chowdhury, B Hadaschik, Y Liu, E Davicioni, MR Smith, EJ Small

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading